Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy patients with deformities at post‐elimination stage: The Bangladesh experience

Mowla MR, Angkur DM, Hasan Z, et al. Wiley. Skin Health and Disease. 2020;
Download PDF
Publication

Hand Disability Grading in Leprosy: Associated Risk Factors

Wardhani RK, Wahyuni LK, Harini M, et al. Indian journal of leprosy. 2020;
Download PDF
Publication

Grade 2 Disability in Leprosy and its Predictors: A 10 year Retrospective Study from Kerala, India

Sabeena J, Bindu RS. Indian journal of leprosy. 2020;
Download PDF
Publication

Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy.

Santos V, Quintans-Júnior L, Barboza W, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020;
Download PDF
Publication

Modelagem espacial da hanseníase no estado da Bahia, Brasil, (2001-2015) e determinantes sociais da saúde

Souza CDFD, Medronho R, Santos FGB, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2020; 25 (8) : 2915-2926.
Download PDF
Publication

Degree of physical disability in hansenic patients in a reference center

Pires CAA, d’Avila Nóvoa T, Ferreira LFB, et al. Brazilian journal of health review. 2020; 3 (4) : 9263-9273.
Download PDF
Publication

The Relationship of Degree of Disability and Quality of Life Among Released From Treatment People Affected by Leprosy in Surabaya, Indonesia

Utama A, Hastuti P, Rustam M. Indian journal of leprosy. 2020;
Download PDF
Publication

Sociodemographic profile and degree of disability in leprosy carrier in a reference center in the state of Ceará

da Costa NMGB, Barbosa TDCS, Queiroz DT, et al. Brazilian Journal of Development. 2020; 6 (6) : 41439-41449.
Download PDF
Publication

Disability progression among leprosy patients released from treatment: a survival analysis.

Rosendo dos Santos A, Silva P, Steinmann P, et al. Infectious diseases of poverty. 2020; 9 (1) : 53.
Download PDF
Publication

Epidemiological monitoring of leprosy indicators in Sergipe (2001–2015): segmented regression analysis

Souza CDFD, Leal TC, Paiva JPSD, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 9
  • Next page ››
Subscribe to Disability grading

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD